step therapy

Step Therapy with Zytiga & Xtandi – Two Equal Drugs Make Our Insurance Companies Our Doctors!

Recently men with advanced prostate cancer have found that their insurance companies have been dictating what drugs they can get instead of their doctor making the best decision for them. At Malecare we have seen that when a man with metastatic castrate resistant prostate cancer (mCRPC) has finished taking chemotherapy they have been steered by [...]

By Malecare|2013-08-13T10:53:39-04:00August 13th, 2013|2nd line hormone therapy, Advanced Prostate Cancer, Advocacy, Cabazitaxel, Chemo Therapy, Chemo Therapy Failure, Drugs & Treatments, Enzalutamide (MDV-3100), General Information, Hormone Therapy, Politics of Cancer, Uncategorized, Understanding APC, Xtandi, Zytiga|2 Comments

Increasing Cost of Treating Men with Advanced Prostate Cancer & Its Effects on the Payers

The treatment of advanced prostate cancer, and in particular castrate resistant prostate cancer (CRPC), has changed greatly over the last 4 years. Treatment options have expanded and now offer multiple treatment possibilities that did not exist 4 years ago. With the addition of all these new options, so comes the addition of significant economic costs, [...]

By Malecare|2013-07-07T07:02:27-04:00July 7th, 2013|Advanced Prostate Cancer, Alpharadin (radium-223), Cabazitaxel, Combination Therapy, Drugs & Treatments, Enzalutamide (MDV-3100), Financial, General Information, How We Live, Insurance, Prostate Ponderings, Research, Uncategorized, Understanding APC, Xofigo, Xtandi, Zytiga|2 Comments

Previous 12